Cargando…
Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
Mycoplasma pneumoniae (MP) is the most common cause of childhood bacterial pneumonia. Although macrolide is known to be effective as a first-line therapy, the proportion of macrolide resistance in MP pneumonia has strikingly increased during recent 2 decades in East Asia. This is challenging to phys...
Autor principal: | Cho, Hye-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Pediatric Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426095/ https://www.ncbi.nlm.nih.gov/pubmed/33561337 http://dx.doi.org/10.3345/cep.2020.01305 |
Ejemplares similares
-
Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management
por: Tong, Lin, et al.
Publicado: (2022) -
Mycoplasma pneumoniae pneumonia in children
por: Youn, You-Sook, et al.
Publicado: (2012) -
Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children
por: You, Sun Young, et al.
Publicado: (2014) -
Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Xie, Qiaoyi, et al.
Publicado: (2022) -
Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis
por: Ahn, Jong Gyun, et al.
Publicado: (2021)